180 related articles for article (PubMed ID: 16799709)
1. Immunohistochemical expression of EGFR and p-EGFR in oral squamous cell carcinomas.
Hiraishi Y; Wada T; Nakatani K; Negoro K; Fujita S
Pathol Oncol Res; 2006; 12(2):87-91. PubMed ID: 16799709
[TBL] [Abstract][Full Text] [Related]
2. Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas.
Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Todd R; Wong DT
Cancer Lett; 2000 Dec; 161(1):9-15. PubMed ID: 11078908
[TBL] [Abstract][Full Text] [Related]
3. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
Pidugu VK; Wu MM; Yen AH; Pidugu HB; Chang KW; Liu CJ; Lee TC
Oncogene; 2019 Apr; 38(17):3232-3247. PubMed ID: 30626937
[TBL] [Abstract][Full Text] [Related]
4. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas.
Bánkfalvi A; Krassort M; Végh A; Felszeghy E; Piffkó J
J Oral Pathol Med; 2002 Sep; 31(8):450-7. PubMed ID: 12220351
[TBL] [Abstract][Full Text] [Related]
5. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
[TBL] [Abstract][Full Text] [Related]
6. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
8. EGFR protein overexpression and mutation in areca quid-associated oral cavity squamous cell carcinoma in Taiwan.
Huang SF; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
Head Neck; 2009 Aug; 31(8):1068-77. PubMed ID: 19360742
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of SGLT1 and EGFR is associated with tumor differentiation in oral squamous cell carcinoma.
Hanabata Y; Nakajima Y; Morita K; Kayamori K; Omura K
Odontology; 2012 Jul; 100(2):156-63. PubMed ID: 21607591
[TBL] [Abstract][Full Text] [Related]
10. pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.
Aquino G; Pannone G; Santoro A; Liguori G; Franco R; Serpico R; Florio G; De Rosa A; Mattoni M; Cozza V; Botti G; Losito S; Longo F; Staibano S; Cuda G; Lo Muzio L; Sbordone C; Bufo P; Grimaldi A; Caraglia M; Di Domenico M
Cancer Biol Ther; 2012 Sep; 13(11):967-77. PubMed ID: 22825335
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
[TBL] [Abstract][Full Text] [Related]
12. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
13. Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma.
Shuyi Y; Feng W; Jing T; Hongzhang H; Haiyan W; Pingping M; Liwu Z; Zwahlen RA; Hongyu Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Nov; 112(5):616-25. PubMed ID: 22035653
[TBL] [Abstract][Full Text] [Related]
14. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
15. Epidermal Growth Factor (EGF) Autocrine Activation of Human Platelets Promotes EGF Receptor-Dependent Oral Squamous Cell Carcinoma Invasion, Migration, and Epithelial Mesenchymal Transition.
Chen R; Jin G; Li W; McIntyre TM
J Immunol; 2018 Oct; 201(7):2154-2164. PubMed ID: 30150285
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
17. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma.
Monteiro LS; Diniz-Freitas M; Garcia-Caballero T; Warnakulasuriya S; Forteza J; Fraga M
J Oral Pathol Med; 2012 Aug; 41(7):559-67. PubMed ID: 22417132
[TBL] [Abstract][Full Text] [Related]
18. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma in relation to proliferation, apoptosis, angiogenesis and lymphangiogenesis.
Sarkis SA; Abdullah BH; Abdul Majeed BA; Talabani NG
Head Neck Oncol; 2010 Jun; 2():13. PubMed ID: 20579333
[TBL] [Abstract][Full Text] [Related]
20. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
